Larazotide

• CAT Number: M013254
• CAS Number: 258818-34-7
• Molecular Formula: C32H55N9O10
• Molecular Weight: 725.845
• Purity: ≥95%
• Synonyms: larazotide;Glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolylglycine;Unii-zn3R5560zv
• Storage: Room temperature
• IUPAC Name: 2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]acetic acid
• InChI: InChI=1S/C32H55N9O10/c1-16(2)12-20(38-30(49)26(17(3)4)39-24(44)14-35-23(43)13-33)28(47)40-27(18(5)6)31(50)37-19(9-10-22(34)42)32(51)41-11-7-8-21(41)29(48)36-15-25(45)46/h16-21,26-27H,7-15,33H2,1-6H3,(H2,34,42)(H,35,43)(H,36,48)(H,37,50)(H,38,49)(H,39,44)(H,40,47)(H,45,46)/t19-,20-,21-,26-,27-/m0/s1
• InChIKey: ORFLZNAGUTZRLQ-ZMBVWFSWSA-N
• SMILES: CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)N1CCCC1C(=O)NCC(=O)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)CN

Reference

1: Storr M. [Larazotide as an option in case of failure of a gluten-free diet].
Med Monatsschr Pharm. 2016 Feb;39(2):89-90. German. PubMed PMID: 26983338.
2: Khaleghi S, Ju JM, Lamba A, Murray JA. The potential utility of tight junction
regulation in celiac disease: focus on larazotide acetate. Therap Adv
Gastroenterol. 2016 Jan;9(1):37-49. doi: 10.1177/1756283X15616576. Review. PubMed
PMID: 26770266; PubMed Central PMCID: PMC4699279.
3: Leffler DA, Kelly CP, Green PH, Fedorak RN, DiMarino A, Perrow W, Rasmussen H,
Wang C, Bercik P, Bachir NM, Murray JA. Larazotide acetate for persistent
symptoms of celiac disease despite a gluten-free diet: a randomized controlled
trial. Gastroenterology. 2015 Jun;148(7):1311-9.e6. doi:
10.1053/j.gastro.2015.02.008. Epub 2015 Feb 13. PubMed PMID: 25683116; PubMed
Central PMCID: PMC4446229.
4: Kelly CP, Green PH, Murray JA, Dimarino A, Colatrella A, Leffler DA, Alexander
T, Arsenescu R, Leon F, Jiang JG, Arterburn LA, Paterson BM, Fedorak RN;
Larazotide Acetate Celiac Disease Study Group.. Commentary: larazotide acetate –
an exciting new development for coeliac patients? Authors/’ reply. Aliment
Pharmacol Ther. 2013 Feb;37(4):496-7. doi: 10.1111/apt.12196. PubMed PMID:
23336684.